For the quarter ending 2026-03-31, TARS has $581,135K in assets. $232,184K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 102,192 | 183,641 | 112,724 | 96,648 |
| Restricted cash | 0 | 560 | - | - |
| Marketable securities | 286,540 | 233,627 | 289,113 | 284,495 |
| Accounts receivable, net | 100,344 | 85,057 | 72,620 | 58,334 |
| Inventory | 4,572 | 4,372 | 3,836 | 3,873 |
| Other receivables | 16,863 | 2,052 | 1,716 | 1,906 |
| Prepaid expenses | 26,718 | 13,473 | 21,695 | 29,173 |
| Total current assets | 537,229 | 522,782 | 501,704 | 474,429 |
| Restricted cash, non-current | 2,001 | 2,002 | 2,563 | 2,563 |
| Inventory, non-current | 2,528 | 2,532 | 2,532 | 2,532 |
| Property and equipment, net | 17,672 | 11,665 | 5,746 | 3,182 |
| Intangible assets, net | 7,126 | 7,366 | 7,606 | 7,846 |
| Operating lease right-of-use assets | 9,994 | 10,080 | 10,233 | 229 |
| Long-term investments | 3,870 | 3,870 | 3,000 | 3,000 |
| Other assets | 715 | 1,861 | 1,177 | 1,213 |
| Total assets | 581,135 | 562,158 | 534,561 | 494,994 |
| Accounts payable | 24,131 | 16,387 | - | - |
| Accrued payroll and benefits | 8,529 | 17,779 | 13,552 | 11,612 |
| Other accrued liabilities | 110,848 | 101,529 | 103,498 | 78,641 |
| Total current liabilities | 143,508 | 135,695 | 117,050 | 90,253 |
| Long-term debt, net | 72,597 | 72,438 | 72,281 | 72,129 |
| Other long-term liabilities | 16,079 | 10,599 | 10,148 | - |
| Total liabilities | 232,184 | 218,732 | 199,479 | 162,382 |
| Common stock, 0.0001 par value 200,000,000 shares authorized 43,021,312 shares issued and outstanding at march31, 2026 (unaudited) 42,553,931 shares issued and outstanding at december31, 2025 | 6 | 6 | 6 | 6 |
| Additional paid-in capital | 782,838 | 769,667 | 753,042 | 738,237 |
| Accumulated other comprehensive income (loss) | -298 | 381 | 289 | 39 |
| Accumulated deficit | -433,595 | -426,628 | -418,255 | -405,670 |
| Total stockholders equity | 348,951 | 343,426 | 335,082 | 332,612 |
| Total liabilities and stockholders equity | 581,135 | 562,158 | 534,561 | 494,994 |
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)